85 related articles for article (PubMed ID: 31700864)
1. Does microvascular invasion in Barcelona Clinic Liver Cancer stage A multinodular hepatocellular carcinoma indicate early-stage behavior?
Wang H; Feng LH; Qian YW; Cao ZY; Wu MC; Cong WM
Ann Transl Med; 2019 Sep; 7(18):428. PubMed ID: 31700864
[TBL] [Abstract][Full Text] [Related]
2. Perioperative and long-term survival outcomes of laparoscopic versus laparotomic hepatectomy for BCLC stages 0-A hepatocellular carcinoma patients associated with or without microvascular invasion: a multicenter, propensity score matching analysis.
Yang SY; Yan ML; Duan YF; Feng JK; Ye JZ; Xiang YJ; Liu ZH; Guo L; Xue J; Cheng SQ; Guo WX
Hepatol Int; 2022 Aug; 16(4):892-905. PubMed ID: 35704267
[TBL] [Abstract][Full Text] [Related]
3. Postoperative lenvatinib + PD-1 blockade reduces early tumor recurrence in hepatocellular carcinoma with microvascular invasion (Barcelona Clinic Liver Cancer stage 0 or A): a propensity score matching analysis.
Danzeng A; Guo L; Yang ZH; He ZW; Zeng CL; Ciren P; Lan RH; Jiang XW; Wang C; Zhang BH
J Gastrointest Surg; 2024 May; ():. PubMed ID: 38723996
[TBL] [Abstract][Full Text] [Related]
4. Association of severity in the grading of microvascular invasion with long-term oncological prognosis after liver resection for early-stage hepatocellular carcinoma: a multicenter retrospective cohort study from a hepatitis B virus-endemic area.
Xu XF; Diao YK; Zeng YY; Li C; Li FW; Sun LY; Wu H; Lin KY; Yao LQ; Wang MD; Zhang CW; Lau WY; Shen F; Yang T
Int J Surg; 2023 Apr; 109(4):841-849. PubMed ID: 36974673
[TBL] [Abstract][Full Text] [Related]
5. Effect of transarterial chemoembolization as postoperative adjuvant therapy for intermediate-stage hepatocellular carcinoma with microvascular invasion: a multicenter cohort study.
Xiang C; Shen X; Zeng X; Zhang Y; Ma Z; Zhang G; Song X; Huang T; Yang J
Int J Surg; 2024 Jan; 110(1):315-323. PubMed ID: 37812183
[TBL] [Abstract][Full Text] [Related]
6. Patterns, Risk Factors, and Outcomes of Recurrence After Hepatectomy for Hepatocellular Carcinoma with and without Microvascular Invasion.
Yu Y; Wang XH; Hu WJ; Chen DH; Hu ZL; Li SQ
J Hepatocell Carcinoma; 2024; 11():801-812. PubMed ID: 38737385
[TBL] [Abstract][Full Text] [Related]
7. Survival effects of postoperative adjuvant TACE in early-HCC patients with microvascular invasion: A multicenter propensity score matching.
Qian J; Shen Y; Cui L; Wu Z; Tu S; Lin W; Tang H; Hu Z; Liu L; Shen W; He Y; He K
J Cancer; 2024; 15(1):68-78. PubMed ID: 38164269
[No Abstract] [Full Text] [Related]
8. Prognosis and safety of laparoscopic hepatectomy for BCLC stage 0/A hepatocellular carcinoma with clinically significant portal hypertension: a multicenter, propensity score-matched study.
Xia F; Zhang Q; Ndhlovu E; Zheng J; Yuan M; Gao H; Xia G
Surg Endosc; 2024 Feb; 38(2):799-812. PubMed ID: 38062182
[TBL] [Abstract][Full Text] [Related]
9. Does perioperative allogeneic blood transfusion worsen the prognosis of patients with hepatocellular carcinoma? A meta-analysis of propensity score-matched studies.
Hu L; Li Z; Qiao Y; Wang A
Front Oncol; 2023; 13():1230882. PubMed ID: 37854678
[TBL] [Abstract][Full Text] [Related]
10. Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteria.
Xu W; Guo R; Xu G; Sun L; Hu D; Xu H; Yang H; Sang X; Lu X; Mao Y
Oncotarget; 2017 Dec; 8(66):110406-110414. PubMed ID: 29299157
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection.
Bai Y; Lian Y; Chen X; Wu J; Lai J; Qiu F; Zhou S; Zhu Z; Tian Y; Wang Y; Yang Y; Yan M
Front Oncol; 2020; 10():616263. PubMed ID: 33585243
[TBL] [Abstract][Full Text] [Related]
12. Histological classification of microvascular invasion to predict prognosis in intrahepatic cholangiocarcinoma.
Shao C; Chen J; Chen J; Shi J; Huang L; Qiu Y
Int J Clin Exp Pathol; 2017; 10(7):7674-7681. PubMed ID: 31966613
[TBL] [Abstract][Full Text] [Related]
13. Time to surgery is not an oncological risk factor in HCC patients undergoing liver resection.
Otto CC; Wang G; Mantas A; Heise D; Bruners P; Lang SA; Ulmer TF; Neumann UP; Heij LR; Bednarsch J
Langenbecks Arch Surg; 2023 May; 408(1):187. PubMed ID: 37160788
[TBL] [Abstract][Full Text] [Related]
14. Impact of Surgical Margin on the Prognosis of Early Hepatocellular Carcinoma (≤5 cm): A Propensity Score Matching Analysis.
Wang H; Yu H; Qian YW; Cao ZY; Wu MC; Cong WM
Front Med (Lausanne); 2020; 7():139. PubMed ID: 32478080
[No Abstract] [Full Text] [Related]
15. Identification of important genes and drug repurposing based on clinical-centered analysis across human cancers.
Li Y; Dong YP; Qian YW; Yu LX; Wen W; Cui XL; Wang HY
Acta Pharmacol Sin; 2021 Feb; 42(2):282-289. PubMed ID: 32555508
[TBL] [Abstract][Full Text] [Related]
16. Preoperative evaluation and prediction of clinical scores for hepatocellular carcinoma microvascular invasion: a single-center retrospective analysis.
He YZ; He K; Huang RQ; Wang ZL; Ye SW; Liu LW; Luo QJ; Hu ZM
Ann Hepatol; 2020; 19(6):654-661. PubMed ID: 32768591
[TBL] [Abstract][Full Text] [Related]
17. A novel signature based on microvascular invasion predicts the recurrence of HCC.
Du B; Wang F; Jarad B; Wang Z; Zhang Y
J Transl Med; 2020 Jul; 18(1):272. PubMed ID: 32631357
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic and prognostic value of UBE2T in intrahepatic cholangiocarcinoma.
Yu H; Wang H; Dong W; Cao ZY; Li R; Yang C; Cong WM; Dong H; Jin GZ
PeerJ; 2020; 8():e8454. PubMed ID: 32025379
[TBL] [Abstract][Full Text] [Related]
19. A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study.
Wang H; Chen JJ; Yin SY; Sheng X; Wang HX; Lau WY; Dong H; Cong WM
J Hepatocell Carcinoma; 2024; 11():191-206. PubMed ID: 38283692
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
